Biosimilar Competition in Oncology—Beyond Insurer Pressure

The high price of drugs continues to be the focus of policy discussions, with attention often drawn to the importance of promoting price competition through the use of generic and biosimilar versions of branded reference products. As occurred with small-molecule drugs and generics after the passage of the Hatch-Waxman Act of 1984, the creation of a biosimilar approval pathway in the Affordable Care Act’s Biologics Price Competition and Innovation Act was intended to lower spending on biologic...

Oz: Millions may be falsely enrolled in ObamaCare

Mehmet Oz, administrator for the Centers for Medicare and Medicaid Services (CMS), claimed in an interview published Monday that millions of people could potentially be falsely enrolled in Affordable Care Act (ACA) plans. In January, early ACA enrollment figures indicated a drop following four consecutive years of record growth, going from 23.6 million enrollees to...

Sanders, Mullin butt heads in Surgeon General confirmation hearing

Sen. Markwayne Mullin (R-Okla.) lashed out against Sen. Bernie Sanders (I-Vt.) over Obamacare during a Senate confirmation hearing on Tuesday for President Trump’s surgeon general pick, Casey Means, leading to a brief but tense exchange between the lawmakers. Mullin used much of his time railing against a “broken” health care system, which he blamed on...

We can reverse America’s decline | Bernie Sanders

It is not good enough just to criticize Trump. We must offer a positive vision that will improve the lives of Americans

At this difficult moment in American history, it’s imperative that we have the courage to be honest with ourselves.

The United States, once the envy of the world, is now a nation in profound decline. For the sake of our children and future generations, we must reverse that decline and change, in very fundamental ways, the direction of our country.

We mus...